Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 15, 2022
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
Yigal Nochomovitz Maintained (ARCT) at Strong Buy with Decreased Target to $86 on, Mar 15th, 2022
Yigal Nochomovitz of Citigroup, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy with Decreased Target from $114 to $86 on, Mar 15th, 2022.
Yigal has made no other calls on ARCT in the last 4 months.
There are 2 other peers that have a rating on ARCT. Out of the 2 peers that are also analyzing ARCT, 1 agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Steven Seedhouse of "Raymond James" Upgraded from Sell to Hold on, Monday, January 31st, 2022
This is the rating of the analyst that currently disagrees with Yigal
- John Abbott of "Wells Fargo" Maintained at Buy with Decreased Target to $107 on, Tuesday, March 1st, 2022
